A carregar...
Bleomycin‐induced pulmonary toxicity and treatment with infliximab: A case report
Given the current understanding of bleomycin‐induced pneumonitis (BIP), the use of tumor necrosis factor alpha (TNF‐α) inhibitors such as infliximab for late‐stage disease appears to be of limited benefit. Further research regarding prevention and management of advanced BIP is required.
Na minha lista:
| Publicado no: | Clin Case Rep |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6186889/ https://ncbi.nlm.nih.gov/pubmed/30349718 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.1790 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|